Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Submitted by
admin
on August 1, 2011 - 10:19am
Source:
Seeking Alpha
News Tags:
Merck
Pfizer
Headline:
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Do Not Allow Advertisers to Use My Personal information
